Stryker Corporation (SYK) Financial Analysis & Valuation | Quarter Chart
Stryker Corporation (SYK)
SYKPrice: $355.86
Fair Value: 🔒
🔒score
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. Thi... more
Stryker Corporation operates as a medical technology company. The company operates through two segme... more
Description
Shares
| Market Cap | $136.09B | Exchange | NYSE |
| Sector | Healthcare | Industry | Medical - Devices |
| Country | US | CEO | Kevin A. Lobo |
| IPO Date | 1980-03-17 | CAGR | 0.15% |
| Employees | 53,000 | Website | www.stryker.com |
| Div. Yield | 0.96% | Payout Ratio | 0.43% |
| Buy Back Yield | 0.13% | Total Yield | 1.09% |
SYK chart loading...
Fundamentals
Technicals
| Enterprise Value | $154.70B | P/E Ratio | 46.72 |
| Forward P/E | 20.27 | PEG Ratio | 0.72 |
| P/S Ratio | 5.58 | P/B Ratio | 6.25 |
| P/CF Ratio | 28.16 | P/FCF Ratio | 33.41 |
| EPS | $7.62 | EPS Growth 1Y | -18.44% |
| EPS Growth 3Y | 18.35% | EPS Growth 5Y | 65.08% |
| Revenue Growth 1Y | 10.95% | Gross Margin | 0.63% |
| Operating Margin | 0.22% | Profit Margin | 0.12% |
| ROE | 0.14% | ROA | 0.06% |
| ROCE | 0.13% | Current Ratio | 1.85 |
| Quick Ratio | 1.13 | Cash Ratio | 0.44 |
| Debt/Equity | 0.76 | Interest Coverage | 33.57 |
| Altman Z Score | 4.74 | Piotroski Score | 5 |